Cargando…

The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction

OBJECTIVE: This study examined the prognostic significance of diabetes and microvascular complications in patients with heart failure with preserved ejection fraction (HFpEF). RESEARCH DESIGN AND METHODS: This analysis included 3,385 patients (mean age 69 ± 9.6 years; 49% male; 89% white) with HFpEF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandesara, Pratik B., O’Neal, Wesley T., Kelli, Heval M., Samman-Tahhan, Ayman, Hammadah, Muhammad, Quyyumi, Arshed A., Sperling, Laurence S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741155/ https://www.ncbi.nlm.nih.gov/pubmed/29051160 http://dx.doi.org/10.2337/dc17-0755

Ejemplares similares

Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial
por: Sandesara, Pratik B., et al.
Publicado: (2018)

Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
por: Ko, Yi-An, et al.
Publicado: (2017)

Living in Food Deserts and Adverse Cardiovascular Outcomes in Patients With Cardiovascular Disease
por: Kelli, Heval M., et al.
Publicado: (2019)

High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes
por: Samman Tahhan, Ayman, et al.
Publicado: (2018)

Myocardial Ischemia and Mobilization of Circulating Progenitor Cells
por: Hammadah, Muhammad, et al.
Publicado: (2018)

Sex Differences in Circulating Progenitor Cells
por: Topel, Matthew L., et al.
Publicado: (2017)

N8‐Acetylspermidine: A Polyamine Biomarker in Ischemic Cardiomyopathy With Reduced Ejection Fraction
por: Nayak, Aditi, et al.
Publicado: (2020)

Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community
por: Gohar, Aisha, et al.
Publicado: (2018)

Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease
por: Kelli, Heval M., et al.
Publicado: (2019)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM
por: Sartore, Giovanni, et al.
Publicado: (2020)

Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population
por: Yap, Jonathan, et al.
Publicado: (2021)

Comment on “Individual and Neighborhood Socioeconomic Status and the Association between Air Pollution and Cardiovascular Disease”
por: Ahmed, Tara, et al.
Publicado: (2017)

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
por: Perreault, Leigh, et al.
Publicado: (2019)

Association between C reactive protein and microvascular and macrovascular dysfunction in sub-Saharan Africans with and without diabetes: the RODAM study
por: Hayfron-Benjamin, Charles Frederick, et al.
Publicado: (2020)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Weerts, Jerremy, et al.
Publicado: (2022)

Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study
por: Tomah, Shaheen, et al.
Publicado: (2023)

Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort
por: Gong, Fei Fei, et al.
Publicado: (2018)

Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease
por: Rother, Ulrich, et al.
Publicado: (2020)

Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016)

Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
por: Sickinghe, Ariane A., et al.
Publicado: (2019)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
por: Erhardsson, Mikael, et al.
Publicado: (2023)

Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi‐Ethnic Study of Atherosclerosis
por: O'Neal, Wesley T., et al.
Publicado: (2017)

Comparison of autonomic stress reactivity in young healthy versus aging subjects with heart disease
por: Gurel, Nil Z., et al.
Publicado: (2019)

Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
por: Fernandes, Amanda D.F., et al.
Publicado: (2021)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
por: Mordi, Ify R., et al.
Publicado: (2020)

Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
por: Bilak, Joanna M, et al.
Publicado: (2022)

Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
por: Sinha, Aish, et al.
Publicado: (2023)

Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report
por: Narang, Nikhil, et al.
Publicado: (2017)

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
por: Joung, Sandy, et al.
Publicado: (2019)

Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
por: Sinha, Aish, et al.
Publicado: (2021)

Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms
por: Fopiano, Katie Anne, et al.
Publicado: (2022)

Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2019)

Effects of a Health‐Partner Intervention on Cardiovascular Risk
por: Al Mheid, Ibhar, et al.
Publicado: (2016)

Marital Status and Outcomes in Patients With Cardiovascular Disease
por: Schultz, William M., et al.
Publicado: (2017)

The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction
por: Ovchinnikov, A. G., et al.
Publicado: (2020)

Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction
por: Wang, Yong, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
por: Charytan, David M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b0r3geiaa9gm899nmpnkessus7